Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Genetic profiling differentiates second primary tumors from metastases in adult metachronous soft tissue sarcoma.

Author:
  • Josefin Fernebro
  • Ana Carneiro
  • Anders Rydholm
  • Henryk Domanski
  • Anna F Karlsson
  • Åke Borg
  • Mef Nilbert
Publishing year: 2008
Language: English
Publication/Series: Sarcoma
Volume: 2008
Issue: 2009 Feb 2
Document type: Journal article
Publisher: Hindawi Publishing Corporation

Abstract english

Purpose. Patients with soft tissue sarcomas (STS) are at increased risk of second primary malignancies, including a second STS, but distinction between metastases and a second primary STS is difficult. Patients and Methods. Array-based comparative genomic hybridization (aCGH) was applied to 30 multiple STS of the extremities and the trunk wall from 13 patients. Different histotypes were present with malignant fibrous histiocytomas/undifferentiated pleomorphic sarcomas being the predominant subtype. Results. aCGH profiling revealed genetic complexity with multiple gains and losses in all tumors. In an unsupervised hierarchical cluster analysis, similar genomic profiles and close clustering between the first and subsequent STS were identified in 5 cases, suggesting metastatic disease, whereas the tumors from the remaining 8 patients did not cluster and showed only weak pairwise correlation, suggesting development of second primary STS. Discussion. The similarities and dissimilarities identified in the first and second STS suggest that genetic profiles can be used to distinguish soft tissue metastases from second primary STS. The demonstration of genetically different soft tissue sarcomas in the same patient suggests independent tumor origin and serves as a reminder to consider development of second primary STS, which has prognostic and therapeutic implications.

Keywords

  • Cancer and Oncology

Other

Published
  • ISSN: 1357-714X
Åke Borg
Åke Borg
E-mail: ake [dot] borg [at] med [dot] lu [dot] se

Principal investigator

Oncology and Pathology, MV

+46 46 275 25 52

MV 404 C21B2

90

Project manager

Familial Breast Cancer

90

Professor

Oncology and Pathology, MV

MV 404 C21C2

90